Skip to main content
Clinical Trials/NCT05682989
NCT05682989
Recruiting
Not Applicable

Evaluation of Efficacy and Safety of Urogynecology Synthetic Mesh Surgery in Women With Pelvic Organ Prolapse

Mackay Medical College1 site in 1 country150 target enrollmentAugust 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pelvic Organ Prolapse
Sponsor
Mackay Medical College
Enrollment
150
Locations
1
Primary Endpoint
trans-vaginal mesh repair
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

This is a retrospective cohort study, aiming at analyzing the efficacy and safety of mesh surgery in pelvic organ prolapse. The synthetic mesh for pelvic organ prolapse include transvaginal mesh or laparotomy, laparoscope, or robotic-assisted laparoscopic sacrocolpopexy with mesh augmentation. The investigators would like to evaluate the efficacy and safety, such as recurrence rates and complication rates for women who underwent urogynecology mesh surgery.

Detailed Description

Gynecologic mesh, including transvaginal mesh and mesh used in abdominal or laparoscopic sacrocolpopexy, has been used for pelvic organ prolapse since its debut in the US in 2005. It provides higher success and satisfaction rate than traditional colporrhaphy, but mesh-related complications, such as pain, mesh exposure and bleeding, have been reported. U.S. Food and Drug Administration issued a Safety Update in 2011 to inform the public that serious complications associated with synthetic mesh for the transvaginal repair of POP were common. Taiwan FDA and associated committees decided that the use of gynecologic mesh should be regulated. Thorough study and evaluation are needed.

Registry
clinicaltrials.gov
Start Date
August 1, 2022
End Date
December 31, 2027
Last Updated
3 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Chin-Tsung Shen

The Office of Research and Development

Mackay Medical College

Eligibility Criteria

Inclusion Criteria

  • Pelvic organ prolapse patients with objective / subjective voiding dysfunctions
  • Underwent surgery for symptomatic POP ≥ stage II (POP-Q system)

Exclusion Criteria

  • Patients with a history of pelvic radiation.
  • Patients with a history of vesico-/recto-/urethra-vaginal fistula
  • Patients unable to be followed up.

Outcomes

Primary Outcomes

trans-vaginal mesh repair

Time Frame: Generally in our hospital, pre-operative investigation will be done about 30 days before surgery, post-operative investigation will within 1year after surgery.

Urodynamic investigations (The urodynamic study included free uroflowmetry, postvoid residual, filling and voiding cystometry, and a urethral pressure profile. The filling cystometry and urethral pressure profile were performed with 37 degrees C normal saline similar to body temperature at an infusion rate of 80 ml/min. 1. The urodynamic data of POP patient with grade \> or = II, will be retrograde analyzed and and compared. 2. Pressure-associated parameters, such as abdominal pressure (Pabd), detrusor pressure (Pdet) will be measured as centimeter of water column (cmH2O), volume-associated parameters, such as infused volume (Vinf), voided volume (Vvod) and intravesical volume (Vive) will measured as ml. Derived parameter will be expressed as their results of calculation.

Study Sites (1)

Loading locations...

Similar Trials